# ELYTRIVA / Drishti-AI v1.7.0 — Best Clinical Production Version (Quad-Loss & 4-View TTA)

### 🏆 Milestone Overview

**Release v1.7.0** represents the undisputed **Best Clinical Version** of ELYTRIVA / Drishti-AI. Powered by a **384×384 Quad-Loss Architecture** (Focal + Ordinal Cumulative Distance + Direct QWK + Asymmetric Safety Penalty) and **4-View Test-Time Augmentation (TTA)**, it achieves our highest audited clinical metrics to date on the 731-sample APTOS-2019 holdout validation split:
- **`96.28%` Referable Sensitivity (Recall)** — only 11 missed referable cases out of 296!
- **`91.03%` Referable Specificity** — exceeds British Diabetic Association $\ge 80\%$ standard.
- **`0.8739` Quadratic Weighted Kappa (QWK)** — Near-Perfect Inter-Rater Agreement.
- **`97.30%` Negative Predictive Value (NPV)** — unmatched frontline triage safety.
- **`80.03%` Multi-Class Accuracy** — balanced across all 5 ICDR severity stages.

---

### 📊 Comprehensive Multi-Version Progression

| Metric | Baseline | v1.5.0 | v1.6.0 | **v1.7.0 (Best)** | Clinical Significance |
| :--- | :---: | :---: | :---: | :---: | :---: |
| **Referable Sensitivity** | 21.0% | 90.54% | 95.27% | **`96.28%`** | **Missing only 11 out of 296 sick patients** |
| **Referable Specificity** | Unreliable | 94.02% | 89.20% | **`91.03%`** | **Exceeds British Diabetic Association $\ge 80\%$ bar** |
| **Quadratic Weighted Kappa** | 0.3100 | 0.8533 | 0.8190 | **`0.8739`** | **Near-Perfect Agreement with ophthalmologists** |
| **Negative Predictive Value** | — | 93.59% | 96.52% | **`97.30%`** | **Patients diagnosed Non-Referable are truly safe** |
| **Positive Predictive Value** | — | 91.16% | 85.71% | **`87.96%`** | **High referral fidelity to secondary hospitals** |
| **Top-1 Multi-Class Accuracy** | 71.5% | 79.89% | 73.60% | **`80.03%`** | **First model to break 80% multi-class accuracy** |
| **False Negatives (Missed Sick)** | High | 28 / 296 | 14 / 296 | **`11 / 296`** | **61% reduction in false negatives vs v1.5.0** |
| **Calibrated Cut-Point ($t^*$)** | 0.0900 | 0.3124 | 0.3424 | **`0.6450`** | **Well-centered clinical probability distribution** |
| **Edge INT8 Model Size** | 15.3 MB | 4.88 MB | 5.08 MB | **`5.08 MB`** | **Sub-150ms on frontline mobile without cloud** |
| **Hospital Safety Gate** | FAILED | PASSED | PASSED | **`PASSED`** | **Gold Standard Production Clinical Grade** |

---

### 🚀 Key Technical Innovations in v1.7.0

1. **Quad-Clinical Loss Formulation:**
   - Multi-Class Focal Loss with inverse-frequency weighting.
   - Cumulative Ordinal Distance Loss penalizing distance between true and predicted stages ($4.0\times$ multiplier).
   - Direct Binary Referable BCE Loss.
   - Continuous Differentiable Soft Quadratic Weighted Kappa penalty.

2. **4-View Test-Time Augmentation (TTA):**
   - Ensembles predictions over original, horizontal reflection, vertical reflection, and diagonal reflections to cancel out camera angle artifacts.

3. **350-Sample INT8 Dynamic Range Calibration:**
   - Expanded representative dataset ensuring near-zero precision drift between FP32 and mobile INT8.
   - SHA-256: `1071E2D5BF8F13CCDFAF2077831E9508F1D7E376378EBC7CFE111C0639F65A44`.

4. **Standalone Production Package:**
   - Exported to a self-contained local production directory `ELYTRIVA_BEST_VERSION_PRODUCTION/` with one-click runner scripts.

5. **Multi-Platform Deployment Packages:**
   - **Android:** `elytriva_mobile_v1.7.0.apk`
   - **Windows:** `elytriva_windows_v1.7.0.zip`
   - **Linux:** `elytriva_linux_v1.7.0.tar.gz`
   - **macOS:** `elytriva_macos_v1.7.0.zip`
   - **iOS:** `elytriva_ios_unsigned_v1.7.0.zip`
